Clinical Trial Update: 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study evaluated a fixed-dose Travoprost/brinzolamide ophthalmic suspension in open-angle glaucoma or ocular hypertension; results fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travoprost/brinzolamide ophthalmic suspension

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-12-29